CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-01 | Myszkowski Kenneth Allen Chief Financial Officer | Grant or award | +85,000 | 395,815 | ||
| 2019-01-01 | GIVEN BRUCE D Chief Operating Officer | Grant or award | +210,000 | 1,118,356 | ||
| 2019-01-01 | Anzalone Christopher Richard Chief Executive Officer | Grant or award | +600,000 | 2,142,455 | ||
| 2018-12-27 | GIVEN DOUGLAS B Director | Sale | −3,000 | $12.00 | $36K | 145,130 |
| 2018-12-19 | Anzalone Christopher Richard Chief Executive Officer | Sale | −90,000 | $13.92 | $1.3M | 1,542,455 |
| 2018-12-18 | Ferrari Mauro Director | Grant or award | +3,459 | 16,227 | ||
| 2018-12-12 | Anzalone Christopher Richard Chief Executive Officer | Sale | −90,000 | $14.07 | $1.3M | 1,632,455 |
| 2018-11-23 | GIVEN DOUGLAS B Director | Sale | −3,000 | $12.74 | $38K | 148,130 |
| 2018-11-09 | Anzalone Christopher Richard Chief Executive Officer | Sale | −76,200 | $14.35 | $1.1M | 1,727,755 |
| 2018-11-09 | Anzalone Christopher Richard Chief Executive Officer | Sale | −5,300 | $14.95 | $79K | 1,722,455 |
| 2018-10-22 | GIVEN DOUGLAS B Director | Gift | −3,870 | 151,130 | ||
| 2018-10-19 | Leone Peter Brian VP, Strategic Bus. Initiatives | Option exercise | +30,000 | $2.79 | $84K | 160,000 |
| 2018-10-19 | Leone Peter Brian VP, Strategic Bus. Initiatives | Option exercise | +34,375 | $6.15 | $211K | 194,375 |
| 2018-10-19 | Leone Peter Brian VP, Strategic Bus. Initiatives | Option exercise | +66,762 | $7.75 | $517K | 261,137 |
| 2018-10-19 | Leone Peter Brian VP, Strategic Bus. Initiatives | Sale | −131,137 | $13.49 | $1.8M | 130,000 |
| 2018-10-19 | Leone Peter Brian VP, Strategic Bus. Initiatives | Option exercise · Stock Options | −30,000 | 190,000 | ||
| 2018-10-19 | Leone Peter Brian VP, Strategic Bus. Initiatives | Option exercise · Stock Options | −34,375 | 155,625 | ||
| 2018-10-19 | Leone Peter Brian VP, Strategic Bus. Initiatives | Option exercise · Stock Options | −66,762 | 88,863 | ||
| 2018-09-06 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +25,000 | $2.62 | $66K | 335,815 |
| 2018-09-06 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +20,000 | $4.75 | $95K | 355,815 |
Page 33 of 38 · 752 trades